Review
Copyright ©2010 Baishideng.
World J Gastroenterol. Feb 28, 2010; 16(8): 934-947
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.934
Table 1 Conventional corticosteroid treatment regimens for autoimmune hepatitis[19,54,55]
ScheduleMonotherapy
Combination therapy
Prednisone only1 (mg/d)Prednisone1 (mg/d)Azathioprine (mg/d)
Induction period
Week 1603050
Week 2402050
Week 3301550
Week 4301550
Maintenance period
Fixed doses until end point201050
Conditions that favor each regimenCytopenia (severe) Absent thiopurine methyltransferase activity Pregnancy Malignancy (active) Short trial ( ≤ 6 mo) Acute severe onsetElderly/postmenopausal state Osteoporosis Brittle diabetes Obesity Acne Emotional instability/psychosis Hypertension Prolonged therapy (≥ 6 mo)
Table 2 Difficult treatment decisions before starting conventional corticosteroid therapy
ProblemResponse
Acute severe (fulminant) presentationPrompt institution of conventional corticosteroid therapy with prednisone monotherapy[44,51-53]
Azathioprine, 50 mg/d, can be added later if treatment is to be continued for ≥ 3 mo[55]
Liver transplantation evaluation if laboratory indices worsen at any time during treatment, especially progressive hyperbilirubinemia, or no improvement after 2 wk[56]
Asymptomatic mild or mild diseaseInstitute conventional corticosteroid therapy with prednisone in combination with azathioprine[58,55]
Consider empirical treatment with budesonide, 3 mg tid, in conjunction with azathioprine, 50 mg/d, if preexistent osteopenia, diabetes, hypertension, obesity, or emotional instability[25,26]
Autoantibody-negativityExclude viral, drug, toxic, metabolic causes and celiac disease[31,43]
Apply codified scoring criteria of IAIHG for probable or definite diagnosis[31,46]
Institute conventional corticosteroid therapy with prednisone in combination with azathioprine or a higher dose of prednisone alone[19,47-50]
Overlap syndromesConventional corticosteroid therapy alone or in combination with azathioprine if serum alkaline phosphatase level < 2 times ULN[59-62]
Add ursodeoxycholic acid, 13-15 mg/kg per day, to corticosteroid regimen if serum alkaline phosphatase level ≥ 2 times ULN[60,63]
Consider ursodeoxycholic acid alone, 13-15 mg/kg per day, if predominant features of PBC with minimal features of autoimmune hepatitis[64,65]
Table 3 Difficult treatment decisions during conventional corticosteroid therapy
ProblemResponse
Determining treatment end pointContinue conventional therapy until normal serum AST, ALT, bilirubin and γ-globulin levels and normal liver tissue or inactive cirrhosis (ideal end point)[119-121]
Continue conventional therapy until serum AST ≤ 2 times ULN, bilirubin and γ-globulin levels normal, and portal hepatitis or minimally active cirrhosis (satisfactory end point)[11,54,55]
Decrease dose of culprit drug or discontinue its use if side effects emerge (drug toxicity end point)[13,55]
Limit conventional corticosteroid treatment of patients aged ≥ 60 yr if an ideal or satisfactory end point has not been achieved ≤ 24 mo (incomplete response end point)[11,19,124,125]
Relapse after drug withdrawalInstitute original therapy until clinical and laboratory resolution, then increase azathioprine dose to 2 mg/kg per day as dose of prednisone is withdrawn[126,127]
Continue daily azathioprine in fixed dose indefinitely[126,127]
Use low dose prednisone ( ≤ 10 mg/d) if severe cytopenia (leukocyte counts < 2.5 × 109/L or platelet counts < 50 × 109/L) or other azathioprine intolerances[13,55]
Use low dose prednisone (2.5-5 mg/d) to supplement azathioprine maintenance if abnormal serum AST level[55,128]
Treatment failurePrednisone, 60 mg/d, or prednisone, 30 mg/d, in combination with azathioprine, 150 mg/d, for at least 1 mo, then dose reductions by 10 mg for prednisone and 50 mg for azathioprine each month of laboratory improvement until conventional doses reached[54,55,129]
Evaluate for liver transplantation if minimal criteria for listing (MELD ≥ 15 points) are met[130-132]
Incomplete responseAzathioprine (2 mg/kg per day) indefinitely after corticosteroid withdrawal[54,55,127]
Low-dose prednisone ( ≤ 10 mg/d) if azathioprine intolerance[54,55,128]
Adjustments to maintain serum AST level ≤ 3 times ULN[55,133]
Table 4 Difficult treatment decisions after conventional corticosteroid therapy
ProblemResponse
Empirical salvage drugsConsider cyclosporine (5-6 mg/kg per day)[144-150] or tacrolimus (4 mg bid)[21,22,151,152] if progressive disease on conventional treatment
Consider mycophenolate mofetil (1 g bid) if corticosteroid or azathioprine intolerance[23,24,153-159]
Consider budesonide (3 mg tid) as frontline therapy if mild disease or if azathioprine maintenance insufficient after relapse or incomplete response[25,26]
Complete benefit-risk and cost analyses before use[160,161]
Empirical trial must not supersede liver transplantation[55,130,131]
Liver transplantationConsider if acute severe (fulminant) presentation unresponsive or worse within 2 wk of conventional treatment[52,53,56,57]
Consider if treatment dependent ≥ 3 yr and features of decompensation develop (ascites, encephalopathy or variceal bleeding)[130]
Consider if failure to conventional therapy and MELD score ≥ 15 points[52,131,132]
Elderly patients (aged ≥ 60 yr)Restrict conventional therapy to combination regimen[124]
Limit initial treatment to ≤ 24 mo[125]
Institute azathioprine maintenance therapy (2 mg/kg per day) if initial response is incomplete at 24 mo[124]
Consider liver transplantation if features of decompensation emerge[132]
Pregnant patientsCounsel regarding risks of prematurity and infant mortality[162-167]
Institute high-risk obstetrical care[30,162]
Avoid azathioprine if possible[165,168]
Reduce doses of prednisone to lowest levels to stabilize if not resolve laboratory indices[169]
Reestablish conventional prednisone doses prior to delivery[169]
Be alert to post-partum flares[163,164,169]